QA: Clene Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001822791_2026_Clene_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001822791, Clene Inc

  xvar xval
0 AssetsCurrent 8,977,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 9,154,000
4 LiabilitiesCurrent 10,776,000
5 LiabilitiesNoncurrent 3,250,000
6 remainder_Liabilities 21,697,000
7 CostOfGoodsAndServicesSold 45,029
8 SellingGeneralAndAdministrativeExpense 9,665,794
9 ResearchAndDevelopmentExpense 14,488,344
10 remainder_Expenses 0
11 remainder_Revenues 162,818
12 remainder_NetIncome -4,230,111
13 remainder_ComprehensiveNetIncome -127,999
  yvar yval
0 Assets 18,131,000
1 Liabilities 35,723,000
2 Expenses 24,199,167
3 Revenues 162,818
4 StockholdersEquity -17,592,000
5 NetIncome -28,266,460
6 ComprehensiveNetIncome -28,330,460
7 BaseVar 41,287,048
8 EconomicCapitalRatiobeforeLimitedLiability -2.48
9 EconomicCapitalRatio 0.864

Edgar->Model Mapping

Feature Distribution

Change over Time